Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Benekli

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of Cancer Research and Clinical Oncology|March 7, 2013
Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancerOnder Tonyali, Mustafa Benekli, Veli Berk, et al.
Wiener Klinische Wochenschrift|March 16, 2016
Crizotinib-induced toxicity in an experimental rat modelOzge Gumusay, Guldal Esendagli-Yilmaz, Aytug Uner, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.
Japanese Journal of Clinical Oncology|March 4, 2015
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sitesOzge Gumusay, Mustafa Benekli, Ozgur Ekinci, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 9, 2008
Gemcitabine-induced acute coronary syndrome: a case reportBanu Ozturk, Gulten Tacoy, Ugur Coskun, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2010
The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Suleyman Buyukberber, et al.
Medical Oncology (Northwood, London, England)|May 20, 2008
Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimensUgur Coskun, Ali Osman Kaya, Süleyman Buyukberber, et al.
Breast Care (Basel, Switzerland)|April 10, 2014
Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) ExperienceBulent Cetin, Mustafa Benekli, Faysal Dane, et al.
Expert Review of Anticancer Therapy|August 23, 2016
Renal cell cancer: overview of the current therapeutic landscapeMustafa Erman, Mustafa Benekli, Mert Basaran, et al.
Oncotargets and Therapy|December 31, 2014
Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish populationMustafa Benekli, Suayib Yalcin, Metin Ozkan, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of Cancer Research and Clinical Oncology|March 7, 2013
Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancerOnder Tonyali, Mustafa Benekli, Veli Berk, et al.
Wiener Klinische Wochenschrift|March 16, 2016
Crizotinib-induced toxicity in an experimental rat modelOzge Gumusay, Guldal Esendagli-Yilmaz, Aytug Uner, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.
Japanese Journal of Clinical Oncology|March 4, 2015
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sitesOzge Gumusay, Mustafa Benekli, Ozgur Ekinci, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 9, 2008
Gemcitabine-induced acute coronary syndrome: a case reportBanu Ozturk, Gulten Tacoy, Ugur Coskun, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2010
The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Suleyman Buyukberber, et al.
Medical Oncology (Northwood, London, England)|May 20, 2008
Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimensUgur Coskun, Ali Osman Kaya, Süleyman Buyukberber, et al.
Breast Care (Basel, Switzerland)|April 10, 2014
Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) ExperienceBulent Cetin, Mustafa Benekli, Faysal Dane, et al.
Expert Review of Anticancer Therapy|August 23, 2016
Renal cell cancer: overview of the current therapeutic landscapeMustafa Erman, Mustafa Benekli, Mert Basaran, et al.
Oncotargets and Therapy|December 31, 2014
Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish populationMustafa Benekli, Suayib Yalcin, Metin Ozkan, et al.
Pageof 13